Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Ranbaxy To Spin Off Drug Discovery Arm

October 29, 2007 | A version of this story appeared in Volume 85, Issue 44

Ranbaxy Laboratories has taken the first steps to spinning off its drug discovery unit. The Indian company says establishing independence for the R&D unit will provide the flexibility needed to accelerate development of its drug pipeline. Ranbaxy is one of a number of Indian companies previously focused on generic drugs or contract research that have forged into internal drug discovery. This summer, Nicholas Piramal India revealed plans to create a separate R&D unit.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.